+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cranial irradiation as an additional risk factor for anthracycline cardiotoxicity in childhood cancer survivors: an analysis from the cardiac risk factors in childhood cancer survivors study



Cranial irradiation as an additional risk factor for anthracycline cardiotoxicity in childhood cancer survivors: an analysis from the cardiac risk factors in childhood cancer survivors study



Pediatric Cardiology 34(4): 826-834



Anthracycline-treated childhood cancer survivors experience cardiac damage that results in decreased left ventricular (LV) mass, leading to increased LV wall stress, which underlies their greater risk of cardiomyopathy. Many of these survivors also are at risk of growth hormone (GH) abnormalities from cranial irradiation exposure, although it is unknown whether such exposure is associated with cardiotoxicity. Echocardiograms and insulin-like growth factor-1 (IGF-1), a marker of GH, were measured in 130 anthracycline-treated childhood cancer survivors, 59 of whom had been exposed to cranial irradiation, a mean 10 years after their cancer diagnosis. Echocardiographic parameters and IGF-1 were standardized relative to age or body surface area using data from sibling control subjects and expressed as the percentage difference from normal values. The results showed that after adjustment for other risk factors, survivors exposed to cranial irradiation had an additional 12 % decrease in LV mass compared with unexposed survivors (P < 0.01) and an additional 3.6 % decrease in LV dimension (P = 0.03). Survivors exposed to cranial irradiation also had a 30.8 % decrease in IGF-1 relative to normal values, which was greater than the 10.5 % decrease in unexposed survivors (P < 0.01). The above findings led us to conclude that in anthracycline-treated childhood cancer survivors a mean 10 years after their diagnosis, those with cranial irradiation exposure had significantly greater decreases in LV mass and dimension. Because cranial irradiation also was associated with decreased IGF-1, it is possible that GH deficiencies mediated this effect, suggesting that GH replacement therapy may help to prevent the development of cardiotoxicity.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036624969

Download citation: RISBibTeXText

PMID: 23080542

DOI: 10.1007/s00246-012-0539-6


Related references

Aggregating traditional cardiovascular disease risk factors to assess the cardiometabolic health of childhood cancer survivors: an analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study. American Heart Journal 163(2): 295-301.E2, 2012

Dietary quality, caloric intake, and adiposity of childhood cancer survivors and their siblings: an analysis from the cardiac risk factors in childhood cancer survivors study. Nutrition and Cancer 65(4): 547-555, 2013

Exercise capacity in long-term survivors of pediatric cancer: an analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study. Pediatric Blood and Cancer 60(4): 663-668, 2013

Treatment-related cardiotoxicity in childhood cancer survivors: Risk factors and follow-up. La Revue de Medecine Interne 38(2): 125-132, 2016

Therapy-Related Cardiac Risk in Childhood Cancer Survivors: An Analysis of the Childhood Cancer Survivor Study. Journal of Clinical Oncology 2019: Jco1801764, 2019

Evaluation of traditional and novel measures of cardiac function to detect anthracycline-induced cardiotoxicity in survivors of childhood cancer. Journal of Cancer Survivorship 8(2): 183-189, 2015

Anthracycline associated cardiotoxicity in survivors of childhood cancer. Heart 94(4): 525-533, 2008

Anthracycline-associated cardiotoxicity in survivors of childhood cancer. Pediatric Cardiology 32(3): 342-353, 2011

Anthracycline-related cardiotoxicity in childhood cancer survivors. Current Opinion in Cardiology 29(1): 103-112, 2014

Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors. Pediatric Cardiology 36(6): 1112-1119, 2016

Anthracycline cardiotoxicity in long-term survivors of childhood cancer. Cardiovascular Toxicology 7(2): 122-128, 2007

Are cardiac magnetic resonance imaging and radionuclide ventriculography good options against echocardiography for evaluation of anthracycline induced chronic cardiotoxicity in childhood cancer survivors?. Pediatric Hematology and Oncology 31(3): 237-252, 2015

Risk factors for obesity in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Journal of Clinical Oncology 30(3): 246-255, 2012

Risk factors for smoking among adolescent survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Pediatric Blood & Cancer 58(3): 428-434, 2012

Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study. International Journal of Radiation Oncology, Biology, Physics 84(1): 224-230, 2012